Mallick Parag → Nautilus Biotechnology, Inc. NAUT

Stake: 17.40% Shares: 22,263,911 CUSIP: 63909J108 Class: Common stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.30

1,448,757 shares short · +74.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $119K

Point72 Asset Mgmt

Post-Filing Returns · since 2025-03-03 on NAUT

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 1.69 on closest trading day on/after 2025-03-03. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Nautilus Biotechnology, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-30	SCHEDULE 13D/A	AH Bio Fund II, L.P.	—	8,366,966	view →
2026-06-04	SCHEDULE 13D/A	AH Bio Fund II, L.P.	9.90%	11,682,032	view →
2025-03-05	SCHEDULE	Patel Sujal M	15.70%	20,297,732	view →
2025-01-31	SCHEDULE	PERCEPTIVE ADVISORS LLC	10.00%	12,594,211	view →
2023-03-01	SC	Nautilus Biotechnology, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →